Intratumoral hepatic stellate cells as a poor prognostic marker and a new treatment target for hepatocellular carcinoma

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Sun, Bin ^a   Zhang, Xiaofeng ^a   Cheng, Xianshuo ^a   Zhang, Yu ^a   Chen, Lei ^a   Shi, Lehua ^a   Liu, Zhenyu ^a   Qian, Haihua ^a   Wu, Mengchao ^a   Yin, Zhengfeng ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

UVOMORULIN;

ADULT; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CELL ISOLATION; CELL MIGRATION; CELL VIABILITY; CIRCULATING TUMOR CELL; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PHENOTYPE; PROTEIN EXPRESSION; RECURRENCE FREE SURVIVAL; STELLATE CELL; TUMOR INVASION; TUMOR PROMOTION; TUMOR VOLUME;

ANIMALS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; CELL TRANSPLANTATION; EPITHELIAL-MESENCHYMAL TRANSITION; FLAVONOIDS; HEPATIC STELLATE CELLS; HETEROGRAFTS; HUMANS; IN SITU NICK-END LABELING; LIVER NEOPLASMS; MICE; MICE, NUDE; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84894267835     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080212     Document Type: Article

References (44)

1. Cirri P, Chiarugi P (2012) Cancer-associated-fibroblasts and tumor cells: a diabolic liaison driving cancer progression. Cancer Metastasis Rev 31: 195-208. doi:10.1007/s10555-011-9340-x. PubMed: 22101652.
2. Suh YG, Jeong WI (2011) Hepatic stellate cells and innate immunity in alcoholic liver disease. World J Gastroenterol 17: 2543-2551. doi:10.3748/wjg.v17.i20.2543. PubMed: 21633659.
3. Atzori L, Poli G, Perra A (2009) Hepatic stellate cell: a star cell in the liver. Int J Biochem Cell Biol 41: 1639-1642. doi:10.1016/j.biocel.2009.03. 001. PubMed: 19433304.
4. Shariff MI, Cox IJ, Gomaa AI, Khan SA, Gedroyc W et al. (2009) Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics. Expert. Rev Gastroenterol Hepatol 3: 353-367. doi:10.1586/egh.09.35.
5. Liao J, Zhang R, Qian H, Cao L, Zhang Y et al. (2012) Serum profiling based on fucosylated glycoproteins for differentiating between chronic hepatitis B and hepatocellular carcinoma. Biochem Biophys Res Commun 420: 308-314. doi:10.1016/j.bbrc.2012.02.155. PubMed: 22425980.
6. Rubbia-Brandt L, Mentha G, Desmoulière A, Alto Costa AM, Giostra E et al. (1997) Hepatic stellate cells reversibly express alpha-smooth muscle actin during acute hepaticischemia. Transplant Proc 29: 2390-2395. doi:10.1016/S0041-1345(97)00415-6. PubMed: 9270776. (Pubitemid 27373754)
7. Hernandez-Gea V, Friedman SL (2011) Pathogenesis of liver fibrosis. Annu Rev Pathol 6: 425-456. doi:10.1146/annurev-pathol-011110-130246. PubMed: 21073339.
8. Enzan H, Himeno H, Iwamura S, Onishi S, Saibara T et al. (1994) Alpha-smooth muscle actin-positive perisinusoidal stromal cells in human hepatocellular carcinoma. Hepatology 19: 895-903. doi: 10.1002/hep.1840190415. PubMed: 8138263.
9. Terada T, Makimoto K, Terayama N, Suzuki Y, Nakanuma Y (1996) Alpha-smooth muscle actin-positive stromal cells in cholangiocarcinomas, hepatocellular carcinomas and metastatic liver carcinomas. J Hepatol 24: 706-712. doi:10.1016/S0168-8278(96)80267-4. PubMed: 8835746.
10. Hautekeete ML, Geerts A (1997) The hepatic stellate(Ito) cell: its role in human liver disease. Virchows Arch 430: 195-207. doi:10.1007/BF01324802. (Pubitemid 27151929)
11. Faouzi S, Lepreux S, Bedin C, Dubuisson L, Balabaud C et al. (1999) Activation of cultured rat hepatic stellate cells by tumoral hepatocytes. Lab Invest 79: 485-493. PubMed: 10212001. (Pubitemid 29190438)
12. Johnson SJ, Burr AW, Toole K, Dack CL, Mathew J et al. (1998) Macrophage and hepatic stellate cell responses during experimental hepatocarcinogenesis. J Gastroenterol Hepatol 13: 145-151. doi:10.1111/j.1440-1746.1998.tb00629.x. PubMed: 10221815. (Pubitemid 28137913)
13. Théret N, Musso O, Turlin B et al. (2001) Increased extracellular matrix remodeling is associated with tumor progresssion in human hepatocellular carcinoma. Hepatology 34: 82-88. doi:10.1016/S0168-8278(01)81163-6. PubMed: 11431737. (Pubitemid 32591486)
14. Neaud V, Faouzi S, Guirouilh J, Le Bail B, Balabaud C et al. (1997) Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: evidence for a role of hepatocyte growth factor. Hepatology 26: 1458-1466. doi:10.1002/hep.510260612. PubMed: 9397985. (Pubitemid 27520010)
15. Mikula M, Proell V, Fischer AN, Mikulits W (2006) Activated hepatic stellate cells induce tumor progression of neoplastichepatocytes in a TGF-beta dependent fashion. J Cell Physiol 209: 560-567. doi:10.1002/jcp.20772. PubMed: 16883581. (Pubitemid 44484647)
16. Amann T, Bataille F, Spruss T, Mühlbauer M, Gäbele E et al. (2009) Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma. Cancer Sci 100: 646-653. doi:10.1111/j.1349-7006.2009.01087.x. PubMed: 19175606.
17. Zhao W, Zhang L, Yin Z, Su W, Ren G et al. (2011) Activated hepatic stellate cells promote hepatocellular carcinoma development in immunocompetent mice. Int J Cancer 129: 2651-2661. doi:10.1002/ijc.25920. PubMed: 21213212.
18. Santamato A, Fransvea E, Dituri F, Caligiuri A, Quaranta M et al. (2011) Hepatic stellate cells stimulate HCC cell migration via laminin-5 production. Clin Sci (Lond) 121: 159-168. doi:10.1042/CS20110002. PubMed: 21413933.
19. Coulouarn C, Corlu A, Glaise D, Guénon I, Thorgeirsson SS et al. (2012) Hepatocyte-stellate cell cross-talk in the liver engenders a permissive inflammatory microenvironment that drives progression in hepatocellular carcinoma. Cancer Res 72: 2533-2542. doi:10.1158/1538-7445.AM2012-2533. PubMed: 22419664.
20. Thiery JP, Acloque H, Huang RY, Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139: 871-890. doi:10.1016/j.cell. 2009.11.007. PubMed: 19945376.
21. Li J, Liu P, Zhang R, Cao L, Qian H et al. (2011) Icaritin induces cell death in activated hepatic stellate cells through mitochondrial activated apoptosis and ameliorates the development of liver fibrosis in rats. J Ethnopharmacol 137: 714-723. doi:10.1016/j.jep.2011.06.030. PubMed: 21726622.
22. Zhang XF, Lai EC, Kang XY, Qian HH, Zhou YM et al. (2011) Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and a monitor of recurrence of hepatocellular carcinoma after curative liver resection. Ann Surg Oncol 18: 2218-2223. doi:10.1245/s10434-011-1613-7. PubMed: 21336512.
23. Friedman SL, Rockey DC, McGuire RF, Maher JJ, Boyles JK et al. (1992) Isolated hepatic lipocytes and Kupffer cells from normal human liver: morphological and functional characteristics in primary culture. Hepatology 15: 234-243. doi:10.1002/hep.1840150211. PubMed: 1735526.
24. Xu L, Hui AY, Albanis E, Arthur MJ, O'Byrne SM et al. (2005) Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut 54: 142-151. doi:10.1136/gut.2004.042127. PubMed: 15591520. (Pubitemid 40007234)
25. Jiang F, Parsons CJ, Stefanovic B (2006) Gene expression profile of quiescent and activated rat hepatic stellate cells implicates Wnt signalling pathway in activation. J Hepatol 45: 401-409. doi:10.1016/j.jhep.2006.03.016. PubMed: 16780995. (Pubitemid 44142112)
26. Zhou YM, Cao L, Li B, Zhang RX, Sui CJ et al. (2012) Clinicopathological significance of ZEB1 protein in patients with hepatocellular carcinoma. Ann Surg Oncol 19: 1700-1706. doi:10.1245/s10434-011-1772-6. PubMed: 21584833.
27. Zhou YM, Zhang XF, Cao L, Li B, Sui CJ et al. (2012) MCM7 expression predicts post-operative prognosis for hepatocellular carcinoma. Liver Int 32: 1505-1509. doi:10.1111/j.1478-3231.2012.02846.x. PubMed: 22784096.
28. Remmele W, Stegner HE (1987) Recommendation for uniform definition of an immunoreactive score(IRS) for immunohistochemical estrogen receptor detection(ER-ICA) in breast cancer tissue. Pathologe 8: 138-140. PubMed: 3303008.
29. Cassiman D, Libbrecht L, Desmet V, Denef C, Roskams T (2002) Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. J Hepatol 36: 200-209. doi:10.1016/S0168-8278(02)80712-7. PubMed: 11830331. (Pubitemid 34146426)
30. Kellermann MG, Sobral LM, da Silva SD, Zecchin KG, Graner E et al. (2008) Mutual paracrine effects of oral squamous cell carcinoma cells and normal oral fibroblasts: induction of fibroblast to myofibroblast transdifferentiation and modulation of tumor cell proliferation. Oral Oncol 44: 509-517. doi:10.1016/j.oraloncology.2007.07.001. PubMed: 17826300. (Pubitemid 351608623)
31. Xu W, Cao L, Chen L, Li J, Zhang XF et al. (2011) Isolation of circulating tumor cells in patients with hepatocellular carcinoma using a novel cell separation strategy. Clin Cancer Res 17: 3783-3793. doi:10.1158/1078-0432. CCR-10-0498. PubMed: 21527564.
32. Li Y, Li Q, Wang Z, Liang D, Liang S et al. (2009) 15-HETE suppresses K(+) channel activity and inhibits apoptosis in pulmonary artery smooth muscle cells. Apoptosis 14: 42-51. doi:10.1007/s10495-008-0286-6. PubMed: 19082729.
33. Cao L, Zhou Y, Zhai B, Liao J, Xu W et al. (2011) Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines. BMC Gastroenterol 11: 71. doi:10.1186/1471-230X-11-71. PubMed: 21669008.
34. Lugli A, Tornillo L, Mirlacher M, Bundi M, Sauter G et al. (2004) Hepatocyte paraffin 1 expression in human normal and neoplastic tissues: tissue microarray analysis on 3,940 tissue samples. Am J Clin Pathol 122: 721-727. doi:10.1309/KC09YTF2M4DLUYQ6. PubMed: 15491968. (Pubitemid 39434753)
35. Kang N, Gores GJ, Shah VH (2011) Hepatic stellate cells: partners in crime for liver metastases? Hepatology 54: 707-713. doi:10.1002/hep.24384. PubMed: 21520207.
36. Gonda TA, Varro A, Wang TC, Tycko B (2010) Molecular biology of cancer-associated fibroblasts: can these cells be targeted in anticancer therapy? Semin Cell Dev Biol 21: 2-10. doi:10.1016/j.semcdb.2009.10.001. PubMed: 19840860.
37. Xia Y, Chen R, Song Z, Ye S, Sun R et al. (2010) Gene expression profiles during activation of cultured rat hepatic stellate cells by tumoral hepatocytes and fetal bovine serum. J Cancer Res Clin Oncol 136: 309-321. doi:10.1007/s00432-009-0666-5. PubMed: 19727817.
38. Pinzani M, Marra F (2011) Cytokine receptors and sigaling in hepatic stellate cells. Semin Liver Dis 21: 397-416.
39. Friedman SL (2008) Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 88: 125-172. doi:10.1152/physrev. 00013.2007. PubMed: 18195085.
40. Leonardi GC, Candido S, Cervello M, Nicolosi D, Raiti F et al. (2012) The tumor microenvironment in hepatocellular carcinoma. Int J Oncol 40: 1733-1747. PubMed: 22447316.
41. Bonnomet A, Brysse A, Tachsidis A, Waltham M, Thompson EW et al. (2010) Epithelial-to-mesenchymal transitions and circulating tumor cells. J Mammary Gland Biol Neoplasia 15: 261-273. doi:10.1007/s10911-010-9174-0. PubMed: 20449641.
42. Zhang Y, Li J, Cao L, Xu W, Yin Z (2012) Circulating tumor cells in hepatocellular carcinoma: detection techniques, clinical implications, and future perspectives. Semin Oncol 39: 449-460. doi:10.1053/j.seminoncol.2012.05. 012. PubMed: 22846862.
43. Ju MJ, Qiu SJ, Fan J, Xiao YS, Gao Q et al. (2009) Peritumoral activated hepatic stellate cells predict poor clinical outcome inhepatocellular carcinoma after curative resection. Am J Clin Pathol 131: 498-510. doi:10.1309/ AJCP86PPBNGOHNNL. PubMed: 19289585.
44. Yang JD, Nakamura I, Roberts LR (2011) The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets. Semin Cancer Biol 21: 35-43. doi:10.1016/j.semcancer.2010.10.007. PubMed: 20946957.